BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/26/2021 9:58:02 AM | Browse: 487 | Download: 988
 |
Received |
|
2021-02-04 01:33 |
 |
Peer-Review Started |
|
2021-02-04 01:35 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2021-02-25 00:57 |
 |
Revised |
|
2021-02-27 10:43 |
 |
Second Decision |
|
2021-03-25 12:44 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2021-03-26 04:06 |
 |
Articles in Press |
|
2021-03-26 04:06 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2021-04-04 11:03 |
 |
Typeset the Manuscript |
|
2021-05-19 01:52 |
 |
Publish the Manuscript Online |
|
2021-05-26 09:58 |
ISSN |
2307-8960 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Case Report |
Article Title |
Efficacy of artificial liver support system in severe immune-associated hepatitis by camrelizumab: A case report and review of literature
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
You-Wen Tan, Li Chen and Xing-Bei Zhou |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
You-Wen Tan, MD, Chief Doctor, Professor, Department of Hepatology, The Third Hospital of Zhenjiang Affiliated Jiangsu University, No. 300 Danjiamen, Runzhou District, Zhenjiang 212003, Jiangsu Province, China. tyw915@sina.com |
Key Words |
Plasma exchange; Dual plasma molecular adsorption system; Immune checkpoint inhibitors; Immune-associated hepatitis; Case report |
Core Tip |
Immune checkpoint inhibitors can lead to immune-associated hepatitis and severe liver damage that can be life-threatening without specific treatment. Corticosteroids and immunosuppressants do not show sufficient sensitivity and their use often leads to serious complications such as severe secondary infections. Here we report a case of severe liver damage caused by death protein 1 inhibitors and the first use of dual-molecule plasma adsorption combined with plasma exchange to achieve satisfactory results. In addition, the clinical biochemical indicators in this case were sufficient for diagnosing acute liver failure, while pathology provided an accurate diagnosis. Pathological diagnosis is a very important diagnostic tool for severe liver injury. |
Publish Date |
2021-05-26 09:58 |
Citation |
Tan YW, Chen L, Zhou XB. Efficacy of artificial liver support system in severe immune-associated hepatitis by camrelizumab: A case report and review of literature. World J Clin Cases 2021; 9(17): 4415-4422 |
URL |
https://www.wjgnet.com/2307-8960/full/v9/i17/4415.htm |
DOI |
https://dx.doi.org/10.12998/wjcc.v9.i17.4415 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345